Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity: 2016-2025

Historic Common Equity for cbdMD (YCBD) over the last 8 years, with Sep 2025 value amounting to $7.2 million.

  • cbdMD's Common Equity rose 268.04% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 268.04%. This contributed to the annual value of $7.2 million for FY2025, which is 268.04% up from last year.
  • Per cbdMD's latest filing, its Common Equity stood at $7.2 million for Q3 2025, which was up 18.26% from $6.1 million recorded in Q2 2025.
  • cbdMD's Common Equity's 5-year high stood at $103.1 million during Q3 2021, with a 5-year trough of $665,798 in Q1 2025.
  • Moreover, its 3-year median value for Common Equity was $6.1 million (2025), whereas its average is $8.3 million.
  • Its Common Equity has fluctuated over the past 5 years, first crashed by 88.23% in 2024, then soared by 268.04% in 2025.
  • cbdMD's Common Equity (Quarterly) stood at $84.4 million in 2021, then slumped by 68.49% to $26.6 million in 2022, then tumbled by 73.54% to $7.0 million in 2023, then tumbled by 74.68% to $1.8 million in 2024, then skyrocketed by 268.04% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q3 2025, $6.1 million for Q2 2025, and $665,798 during Q1 2025.